Selected data models

You must log in to select data models for download or further analysis.

3 Search results.
Relevance Rating New first Old first

Esophagogastroduodenoscopy Week 38 Mepolizumab HES NCT00086658 - Esophagogastroduodenoscopy Week 38

- 7/15/17 - 1 form, 1 itemgroup, 2 items, 1 language
Itemgroup: Esophagogastroduodenoscopy
Study part: Esophagogastroduodenoscopy Week 38/ Early Withdrawal visit.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Esophagogastroduodenoscopy Week 16 Mepolizumab HES NCT00086658 - Esophagogastroduodenoscopy Week 16

- 7/12/17 - 1 form, 1 itemgroup, 3 items, 1 language
Itemgroup: Esophagogastroduodenoscopy
Study part: Esophagogastroduodenoscopy Week 16.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Esophagogastroduodenoscopy Day 1 Pre-Infusion Mepolizumab HES NCT00086658 - Esophagogastroduodenoscopy Day 1 Pre-Infusion

- 6/11/17 - 1 form, 1 itemgroup, 2 items, 1 language
Itemgroup: Esophagogastroduodenoscopy
Study part: Esophagogastroduodenoscopy Day 1 Pre-Infusion.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial